Frontiers in PharmacologyNeurosciencePeer-reviewed journal article
Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke's encephalopathy: findings in preclinical models and in a postmortem human case
Marta Moya, Berta EscuderoiD, Elena Gómez-Blázquez, Ana Belén Rebolledo PovesiD, Meritxell López‐GallardoiD, Carmen Guerrero, Eva María MarcoiD, Laura OríoiD
Abstract
Wernickes encephalopathy (WE) is a neurologic disease caused by vitamin B1 or thiamine deficiency (TD), being the alcohol use disorder (AUD) its main risk factor. WE patients present limiting motor, cognitive and emotional alterations related to a selective cerebral vulnerability. Neuroinflammation has been proposed as one of the phenomena contributing to brain damage. Our previous studies provide evidence for the involvement of the innate immune receptor Toll-like (TLR) 4 in the inflammatory response induced in the frontal cortex and cerebellum in TD animal models (animals fed with TD diet and receiving pyrithiamine). However, the effects of the combination of chronic alcohol consumption and TD on TLR4 and their specific contribution to the pathogenesis of WE are currently unknown. Additionally, no studies on TLR4 have been conducted on WE patients since brains from these patients are difficult to achieve. Here, we used rat models of chronic alcohol (CA; 9 months of forced consumption of 20% (w/v) alcohol), TD hit (TDD; TD diet + daily 0.25 mg/kg i.p. pyrithiamine during 12 days), or a combined treatment (CA+TDD) to check the activation of the proinflammatory TLR4/MyD88 pathway and related markers in the frontal cortex and the cerebellum. In addition, we characterized for the first time the TLR4 and its co-receptor MyD88 signature, along with other markers of this proinflammatory signaling such as phospo-NF{kappa}B p65 and I{kappa}B, in the post-mortem human frontal cortex and cerebellum (gray and white matter) of an alcohol-induced WE patient, comparing it with negative (no disease) and positive (aged brain with Alzheimers disease) control subjects for neuroinflammation. We found an increase in the cortical TLR4 and its adaptor molecule MyD88, together with an upregulation of the proinflammatory signaling molecules p-NF-B and IB in the CA+TDD animal model. In the patient diagnosed with alcohol-induced WE we observed cortical and cerebellar upregulation of the TLR4/MyD88 pathway. Thus, our findings provide evidence, both in the animal model and the human postmortem brain, of the upregulation of the TLR4/MyD88 proinflammatory pathway in WE related to alcohol consumption.
- Citations
- 9
- FWCI
- 1.05
- Field percentile
- top 23%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ethanol induces neuroimmune dysregulation and soluble TREM2 generation in a human iPSC neuron, astrocyte, microglia triculture model
Andrew J. Boreland, Yara Abbo, … Ronald P. Hart·AlcoholPeer-reviewed·Nov 7, 2025
- Toll-like receptor 3 activation increases voluntary alcohol intake in C57BL/6J male mice
Anna S. Warden, Moatasem M. Azzam, … Robert Adron Harris·Brain Behavior and ImmunityPeer-reviewed·Dec 11, 2018
- INTERFERON-REGULATORY FACTOR 7: A NEUROIMMUNE ROLE FOR VAPOR-INDUCED ESCALATIONS IN ETHANOL SELF-ADMINISTRATION
Dennis F. Lovelock, Joseph M Carew, … Joyce Besheer·bioRxiv·Apr 6, 2026
- Increased alcohol self-administration following repeated Toll-like receptor 3 agonist treatment in male and female rats
Dennis F. Lovelock, Patrick A. Randall, … Joyce Besheer·Pharmacology Biochemistry and BehaviorPeer-reviewed·May 1, 2022
- Effects of innate immune activation by Toll-like receptor agonists on ethanol consumption and preference in FVB/NJ x C57BL/6J hybrid mice.
Brent R. Kisby, Isabel Castro‐Piedras, … Igor Ponomarev·bioRxiv·May 6, 2025
- The toll-like receptor 7 agonist imiquimod increases ethanol self-administration and induces expression of toll-like receptor related genes
Dennis F. Lovelock, Wen Liu, … Joyce Besheer·Addiction BiologyPeer-reviewed·Apr 22, 2022